ValiRx plc risk profile

69 Stretched several inputs deteriorating together

Measured 21 October 2026 from VAL.L's filed statements. Recomputed nightly.

69 (Stretched), driven by Cash conversion at 100, over 5 weighted categories on the MANUFACTURER profile.

What is measured

MechanismReadingBandDirectionDriver
Market expectation88AcuteVolatileOne-year price volatility — 88.8%
Operating pressure69StretchedWorseningCosts outgrowing revenue — +21.6 percentage points
Cash conversion100AcuteStableCapital spending against operating cash — -0.01x
Leverage and coverage36NormalStableInterest cover — -654.14x
Competitive position69StretchedStableOperating-margin gap against peers — -5,667.0 percentage points
ConcentrationReads identified supplier spend, customers above the 10% disclosure threshold and revenue by region. No reading is stored for this company.

These are descriptive readings of disclosed mechanisms, not investment advice, and not a prediction. A band says where a measured input sits, never what to do about it or what happens next.

Healthcare companies with a risk reading

Financials, valuation and price history for ValiRx plc